Analysis of a higher number of dogs with one type of neoplasia (in our area of interest are dogs with lymphoma and osteosarcoma) would increase the statistical power and might reveal statistical significance where it can be only suspected in this study, such as the increases in CD45 + EVs and CD21 + EVs in dogs with cancer. The gene discussed is CR2; the disease is osteosarcoma.